Vericel VCEL
NASDAQ VCEL
$40.19 -0.28 (-0.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vericel (VCEL) Other Non-Current Liabilities (2010 - 2026)

Vericel (VCEL) posted Other Non-Current Liabilities of $1.9 million for Q2 2026, up 1.86% sequentially from $1.9 million in Q1 2026, and up 15.58% YoY from $1.7 million in Q2 2025.

Analysis

Vericel (VCEL) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends

Vericel has reported Other Non-Current Liabilities for 17 years, with the latest figure at $1.9 million in Q2 2026.

  • Quarterly Other Non-Current Liabilities rose 15.58% year-over-year to $1.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.9 million (up 15.58% YoY) and the FY2025 annual result came in at $1.9 million, up 116.44% from the prior year.
  • Other Non-Current Liabilities advanced to $1.9 million in Q2 2026 per VCEL's latest filing, from $1.9 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $1.9 million in Q2 2026 and troughed at $19000.0 in Q1 2022.
  • A 5-year average of $838000.0 and a median of $243000.0 in 2024 frame the typical range for Other Non-Current Liabilities.
  • The sharpest annual moves came in 2022 and 2025: Other Non-Current Liabilities sank 66.67% in 2022, then surged 1100.0% in 2025.
  • Over 5 years, Other Non-Current Liabilities stood at $21000.0 in 2022, then soared by 376.19% to $100000.0 in 2023, then surged by 776.0% to $876000.0 in 2024, then surged by 116.44% to $1.9 million in 2025, then rose by 0.95% to $1.9 million in 2026.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $1.9 million, $1.9 million, and $1.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Vericel 2.05 Bn 1.89 Bn 56.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.91 Mn
Mar 31, 2026 1.88 Mn
Dec 31, 2025 1.90 Mn
Sep 30, 2025 1.67 Mn
Jun 30, 2025 1.66 Mn
Mar 31, 2025 1.85 Mn
Dec 31, 2024 876,000.00
Sep 30, 2024 243,000.00
Jun 30, 2024 198,000.00
Mar 31, 2024 154,000.00
Dec 31, 2023 100,000.00
Sep 30, 2023 65,000.00
Jun 30, 2023 28,000.00
Jun 30, 2022 21,000.00
Mar 31, 2022 19,000.00
Dec 31, 2021 44,000.00
Sep 30, 2021 42,000.00
Jun 30, 2021 62,000.00
Mar 31, 2021 57,000.00
Dec 31, 2020 76,000.00